GE HealthCare (GEHC) fundamentals: P/E, valuation, undervalued?
GE HealthCare · Health Care · ref. ETF XLV · price $68.79
In short — GE HealthCare trades at 15.8× earnings (P/E), 12.7× forward, with a net margin of 9.3 % and revenue growth of +6 %. Read: Cheap for the growth (P/E 13 for ~17% growth (PEG 0.8)).
Is GE HealthCare stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$68.79-4.9% over range
Oct 14, 25low $59.49 · high $88.16Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
54% recommend buying · 13 analysts
Valuation : Cheap for the growth — P/E 13 for ~17% growth (PEG 0.8)
Valuation
15.8
P/E (price/earnings)
12.7
Forward P/E
0.94
PEG
2.8
Price/book (P/B)
$31.3B
Market cap
4.35
EPS
Profitability & growth
9.3 %
Net margin
+6 %
Revenue growth
+17 %
Earnings growth
$10.5B
Total debt
GE HealthCare income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $18.3B | $1.9B | 10.4 % |
| 2023 | $19.6B | $1.6B | 8.0 % |
| 2024 | $19.7B | $2.0B | 10.1 % |
| 2025 | $20.6B | $2.1B | 10.1 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is GE HealthCare's P/E and is the stock undervalued? What's a good P/E?
GE HealthCare's P/E is 15.8 (forward 12.7). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is GE HealthCare profitable?
GE HealthCare has a net margin of 9.3 % (EPS 4.35). The company is profitable.
Is GEHC stock expensive?
Our read: "Cheap for the growth" — P/E 13 for ~17% growth (PEG 0.8). Cross-check with growth and sector.
💬 A question about GE HealthCare? The JPI assistant answers using our backtest data.